Study With Lu AF20513 in Patients With Mild Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI) Due to AD
Status:
Terminated
Trial end date:
2019-06-27
Target enrollment:
Participant gender:
Summary
The purpose of this study is to study the effect of monthly dosing with a single dose of Lu
AF20513, with and without booster vaccine, on antibody response.